Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 137.06
-3.37 %
$ 6.73 B
Market Cap
577.05
P/E
CRL - REVENUE
Revenue CRL - Charles River Laboratories International, Inc.
4.05 B
LAST VALUE
0.93%
2 YEAR CAGR
9.09%
5 YEAR CAGR
12.05%
10 YEAR CAGR